Literature DB >> 31637465

Cardiovascular responses to a glucose drink in young male individuals with overweight/obesity and mild alterations in glucose metabolism, but without impaired glucose tolerance.

Cathriona R Monnard1, Erik Konrad Grasser2.   

Abstract

PURPOSE: Little is known about whether mild aberrations in glucose metabolism, which are seen in overweight/obese subjects (OW/OB) without impaired glucose tolerance, affect regulator control elements for blood pressure homeostasis.
METHODS: Hence, we measured in age-matched male subjects with normal weight (n = 16; BMI = 22.4 kg m-2) and OW/OB (n = 11; BMI = 28.6 kg m-2) continuous beat-to-beat blood pressure, heart rate, stroke volume, myocardial contractility and baroreflex sensitivity during a 30 min baseline and for 120 min after the ingestion of 75 g glucose dissolved in 300 mL tap water (OGTT). Blood samples for the assessment of plasma glucose and insulin were collected at baseline and every 30 min after the drink and homeostatic model assessment of insulin resistance (HOMA-IR) was calculated.
RESULTS: At baseline, glucose (5.3 ± 0.4 SD vs 5.0 ± 0.4 mmol L-1; p = 0.01), insulin (7.4 ± 0.4 vs 3.7 ± 2.7 mU L-1; p = 0.02) and HOMA-IR (1.8 ± 1.3 vs 0.8 ± 0.6; p = 0.01) were significantly higher in subjects with OW/OB, but none classified as having impaired glucose tolerance (plasma glucose levels < 7.8 mmol L-1 at 120 min post-OGTT) or hypertension (all < 130/80 mmHg at baseline). In response to the glucose drink, and in comparison to subjects with normal weight, we observed in subjects with OW/OB a trend towards increased plasma insulin levels (+7445 ± 4858 vs. +4968 ± 1924 mU h L-1; p = 0.08), which was not seen for blood glucose (p = 0.59). Moreover, subjects with OW/OB showed impaired peripheral vasodilation, diminished heart rate and myocardial contractility responses but increased peripheral pulse pressure (all p < 0.05).
CONCLUSIONS: Young male subjects with OW/OB, but without glucose intolerance or hypertension, showed attenuated peripheral vasodilation and diminished cardiac responses to a glucose drink.

Entities:  

Keywords:  Blood pressure; Insulin resistance; Obesity; Sugar

Mesh:

Substances:

Year:  2019        PMID: 31637465     DOI: 10.1007/s00394-019-02120-3

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  30 in total

Review 1.  Perspective: Cardiovascular Responses to Sugar-Sweetened Beverages in Humans: A Narrative Review with Potential Hemodynamic Mechanisms.

Authors:  Cathriona R Monnard; Erik Konrad Grasser
Journal:  Adv Nutr       Date:  2018-03-01       Impact factor: 8.701

2.  Social psychology. Just think: the challenges of the disengaged mind.

Authors:  Timothy D Wilson; David A Reinhard; Erin C Westgate; Daniel T Gilbert; Nicole Ellerbeck; Cheryl Hahn; Casey L Brown; Adi Shaked
Journal:  Science       Date:  2014-07-04       Impact factor: 47.728

3.  Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

Authors:  E Ferrannini; A Natali; P Bell; P Cavallo-Perin; N Lalic; G Mingrone
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 4.  European and US guidelines for arterial hypertension: similarities and differences.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Monica Trapasso; Giorgio Gentile; Maria Gabriella Pinzagli; Adolfo Aita; Paolo Verdecchia
Journal:  Eur J Intern Med       Date:  2019-02-04       Impact factor: 4.487

5.  Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.

Authors:  J W Rowe; J B Young; K L Minaker; A L Stevens; J Pallotta; L Landsberg
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

6.  Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.

Authors:  Samuel Klein; Lora E Burke; George A Bray; Steven Blair; David B Allison; Xavier Pi-Sunyer; Yuling Hong; Robert H Eckel
Journal:  Circulation       Date:  2004-10-27       Impact factor: 29.690

Review 7.  Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.

Authors:  Paul Poirier; Thomas D Giles; George A Bray; Yuling Hong; Judith S Stern; F Xavier Pi-Sunyer; Robert H Eckel
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

Review 8.  Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

Authors:  Caroline S Fox; Sherita Hill Golden; Cheryl Anderson; George A Bray; Lora E Burke; Ian H de Boer; Prakash Deedwania; Robert H Eckel; Abby G Ershow; Judith Fradkin; Silvio E Inzucchi; Mikhail Kosiborod; Robert G Nelson; Mahesh J Patel; Michael Pignone; Laurie Quinn; Philip R Schauer; Elizabeth Selvin; Dorothea K Vafiadis
Journal:  Circulation       Date:  2015-08-05       Impact factor: 29.690

9.  Water ingestion decreases cardiac workload time-dependent in healthy adults with no effect of gender.

Authors:  Cathriona Rosemary Monnard; Erik Konrad Grasser
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

10.  Substantial Inter-Subject Variability in Blood Pressure Responses to Glucose in a Healthy, Non-obese Population.

Authors:  Cathriona R Monnard; Benoît Fellay; Isabelle Scerri; Erik K Grasser
Journal:  Front Physiol       Date:  2017-07-18       Impact factor: 4.566

View more
  1 in total

1.  Sucrose dampens caffeine-induced blood pressure elevations - A randomized crossover pilot study in healthy, non-obese men.

Authors:  Yann Ravussin; Jean-Pierre Montani; Erik Konrad Grasser
Journal:  Front Nutr       Date:  2022-08-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.